Such behavior can lead to "increased stress and job dissatisfaction, at the expense of well-being of breast radiologists,” MD Anderson experts wrote in Clinical Imaging.
Through the end of July, 79% of all AI products authorized by the agency in 2023 are in radiology, followed by 9% in cardiovascular care, and 5% in neurology.
The pause will last until Akumin can restore its systems in a “safe and secure manner,” leaving the company unable to see patients at its fixed-site locations.
More than three-quarters of those reached said they disagree with reducing reimbursement to rads under the 2024 fee schedule, RBMA and MITA reported Thursday.